22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022GlobeNewsWire • 07/27/22
Everyone Says Sell Your Cannabis Stocks! I See It Differently (Podcast Transcript)Seeking Alpha • 07/26/22
22nd Century Group (Nasdaq: XXII) Strengthens Balance Sheet to Accelerate the Expansion of VLN LaunchGlobeNewsWire • 07/21/22
22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq RulesGlobeNewsWire • 07/21/22
Two Tobacco Stocks That Would Be Affected By FDA Limits On Nicotine In CigarettesThe Dog of Wall Street • 06/25/22
22nd Century Group (Nasdaq: XXII) Supports Federal Proposal to Require Less Nicotine in All U.S. CigarettesGlobeNewsWire • 06/22/22
22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor MeetingsGlobeNewsWire • 05/27/22
22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco BusinessGlobeNewsWire • 05/23/22
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis PlatformGlobeNewsWire • 05/18/22
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis CompanyGlobeNewsWire • 05/13/22
22nd Century Group's (XXII) CEO Jim Mish on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/05/22
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022GlobeNewsWire • 05/05/22
22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA's Proposed Ban on Menthol CigarettesGlobeNewsWire • 04/29/22
22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner's Virtual Spring Consumer Cannabis ConferenceGlobeNewsWire • 04/27/22